GSC
AMAG

Ground Swell Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Ground Swell Capital’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$14K Buy
+440
New +$9.38K 0.03% 747

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Ground Swell Capital's AMAG Position: Q3 2014 in Review

Ground Swell Capital opened a new position in AMAG Pharmaceuticals (AMAG) in Q3 2014: 440 shares worth $14K. The stake represents 0.03% of the portfolio and ranks #747 among its holdings.

113 funds tracked by Wall St. Rank hold AMAG as of Q3 2014.

  • Ground Swell Capital held 440 shares of AMAG Pharmaceuticals worth $14K as of Q3 2014.
  • AMAG Pharmaceuticals was a new Ground Swell Capital position in Q3 2014.
  • AMAG Pharmaceuticals made up 0.03% of Ground Swell Capital's portfolio in Q3 2014, its #747 holding.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.